About BioLight
BioLight is a company based in Tel Aviv (Israel) founded in 2005. The company has 4 employees as of December 31, 2024. BioLight operates in a competitive market with competitors including Retinai Medical, Toku Eyes, Big Vision, TearLab and Pr3vent, among others.
- Headquarter Tel Aviv, Israel
- Employees 4 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biolight Life Sciences Ltd.
-
Annual Revenue
$60.06 K (USD)247.62as on Dec 31, 2024
-
Net Profit
-$1.96 M (USD)8.98as on Dec 31, 2024
-
EBITDA
-$2.61 M (USD)2.18as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
4
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BioLight
BioLight is a publicly listed company on the TASE with ticker symbol BOLT in Israel, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of BioLight
Unlock access to complete
Leadership Team
2 people
Dr. Team
1 people
Software Development Team
1 people
Researcher Team
1 people
Unlock access to complete
Funding Insights of BioLight
Detailed funding history for BioLight
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioLight
Investment portfolio details for BioLight
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioLight
Detailed financials for BioLight
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biolight Comparisons
Peer comparison for BioLight
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioLight
BioLight operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Retinai Medical, Toku Eyes, Big Vision, TearLab and Pr3vent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based solutions for the diagnosis of retinal diseases
|
|
| Locked | Locked | Locked |
AI-powered retinal images are analyzed for early disease detection.
|
|
| Locked | Locked | Locked |
Multi-platform systems for ophthalmic diagnosis and analysis are provided.
|
|
| Locked | Locked | Locked |
Developer of diagnostic tests for detecting hyperosmolarity
|
|
| Locked | Locked | Locked |
AI-based platform for newborn ophthalmic condition screening is offered.
|
Detailed competitors of BioLight
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biolight
Complete news archive for BioLight
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioLight
BioLight was founded in 2005.
BioLight is headquartered in Tel Aviv, Israel.
Suzana Nahum Zilberberg is the current CEO of BioLight.
As of Dec 31, 2024, the latest employee count at BioLight is 4.
Annual revenue of BioLight is $60.06K as on Dec 31, 2024.
BioLight is focused on the discovery, development and commercialization of products that address ophthalmic conditions such as glaucoma, dry eye syndrome, or DES, and age-related macular degeneration, or AMD. The company current portfolio is held through its wholly owned subsidiary XLVision, and includes Eye-D (an in-office insertable platform that provides for controlled release of ophthalmic medications over time), IOPtiMate (a surgical system that enables a non-penetrating, CO2 laser-assisted procedure known as CLASS (CO2 Laser-Assisted Sclerotomy Surgery) to reduce elevated IOP), TeaRx ( a diagnostic solution that provides a multi-parameter, objective, rapid, simple, semi-quantitative analysis of tear film in order to identify one or more underlying causes of DES), and OphRx (a non-invasive topical drug delivery technology). BioLight also owns 46 of Micromedic Inc.
BioLight's top competitors include Retinai Medical, Toku Eyes and Pr3vent.
Yes, BioLight is publicly traded on TASE under the ticker symbol BOLT.
The ticker symbol of BioLight is BOLT on TASE.